Publication | Closed Access
Hypofractionated accelerated radiochemotherapy with cytoprotection (Chemo-HypoARC) for inoperable non-small cell lung carcinoma.
19
Citations
10
References
2007
Year
Given the simplicity of HypoARC, the very low morbidity, and the high complete response and survival rates obtained, HypoARC regimens deserve further testing.
| Year | Citations | |
|---|---|---|
Page 1
Page 1